慢性肾脏病成人的心脏结构与功能及后续肾脏病进展:慢性肾功能不全队列(CRIC)研究
该前瞻性观察队列纳入3027例慢性肾脏病(CKD)患者,评估超声心动图所示心脏结构与功能五项指标与肾脏替代治疗(KFRT)及估算肾小球滤过率(eGFR)年下降斜率的关系。中位随访9.9年间883例发生KFRT,左心室质量指数、左心室容积、左心房面积、三尖瓣反流峰值流速升高及射血分数降低均与KFRT风险升高及eGFR下降更快相关(左心房面积除外)。作者认为心脏异常与KFRT发生可能处于同一因果通路。
要点
- 左心室质量指数最高 vs 最低四分位组KFRT风险HR为1.70(95%CI 1.27-2.26)。
- 射血分数最低 vs 最高四分位组KFRT风险HR为1.26(95%CI 1.03-1.56)。
- 除左心房面积外,心脏结构/功能异常组eGFR年下降斜率更快。
核心结论
- 心脏结构与功能的多个方面与KFRT风险呈统计学显著相关。
- 这些发现提示心脏异常与KFRT发生可能处于与高血压、心力衰竭和冠状动脉疾病交互作用相关的同一因果通路。
研究设计与样本
- 前瞻性观察队列研究,纳入慢性肾功能不全队列研究(CRIC)的3027例参与者。
- 暴露为超声心动图评估的五项预设变量:左心室质量指数(LVMI)、左心室容积、左心房(LA)面积、三尖瓣反流(TR)峰值流速和左心室射血分数(EF)。
- 主要结局为 incident KFRT(新发肾脏替代治疗),次要结局为eGFR年下降斜率;分析采用多变量Cox模型和混合效应模型。
主要发现
- 参与者平均年龄59±11 SD岁,54%为男性,平均eGFR为43±17 mL/min/1.73m2。
- 2003年至2018年间(中位随访9.9年),883例参与者发生KFRT。
- LVMI、左心室容积、LA面积、TR峰值流速最高 vs 最低四分位组(EF为最低 vs 最高四分位组)的KFRT风险HR分别为1.70(95%CI 1.27-2.26)、1.50(95%CI 1.19-1.90)、1.43(95%CI 1.11-1.84)、1.45(95%CI 1.06-1.96)和1.26(95%CI 1.03-1.56)。
- 次要结局中,除LA面积外,最高 vs 最低四分位组(EF为最低 vs 最高四分位组)的eGFR年下降斜率差异有统计学意义:LVMI为-0.57(95%CI -0.68至-0.46)mL/min/1.73m2,左心室容积为-0.25(95%CI -0.35至-0.15)mL/min/1.73m2,LA面积为-0.01(95%CI -0.12至0.01)mL/min/1.73m2,TR峰值流速为-0.42(95%CI -0.56至-0.28)mL/min/1.73m2,EF为-0.11(95%CI -0.20至-0.01)mL/min/1.73m2。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Heart-kidney crosstalk is recognized as the cardiorenal syndrome. We examined the association of cardiac function and structure with the risk of kidney failure with replacement therapy (KFRT) in a chronic kidney disease (CKD) population. STUDY DESIGN: Prospective observational cohort study. SETTING & PARTICIPANTS: 3,027 participants from the Chronic Renal Insufficiency Cohort Study. EXPOSURE: Five preselected variables that assess different aspects of cardiac structure and function: left ventricular mass index (LVMI), LV volume, left atrial (LA) area, peak tricuspid regurgitation (TR) velocity, and left ventricular ejection fraction (EF) as assessed by echocardiography. OUTCOME: Incident KFRT (primary outcome), and annual estimated glomerular filtration rate (eGFR) slope (secondary outcome). ANALYTICAL APPROACH: Multivariable Cox models and mixed-effects models. RESULTS: The mean age of the participants was 59±11 SD years, 54% were men, and mean eGFR was 43±17mL/min/1.73m2. Between 2003 and 2018 (median follow-up, 9.9 years), 883 participants developed KFRT. Higher LVMI, LV volume, LA area, peak TR velocity, and lower EF were each statistically significantly associated with an increased risk of KFRT, with corresponding HRs for the highest versus lowest quartiles (lowest vs highest for EF) of 1.70 (95% CI, 1.27-2.26), 1.50 (95% CI, 1.19-1.90), 1.43 (95% CI, 1.11-1.84), 1.45 (95% CI, 1.06-1.96), and 1.26 (95% CI, 1.03-1.56), respectively. For the secondary outcome, participants in the highest versus lowest quartiles (lowest vs highest for EF) had a statistically significantly faster eGFR decline, except for LA area (ΔeGFR slope per year, -0.57 [95% CI, -0.68 to-0.46] mL/min/1.73m2 for LVMI, -0.25 [95% CI, -0.35 to-0.15] mL/min/1.73m2 for LV volume, -0.01 [95% CI, -0.12 to-0.01] mL/min/1.73m2 for LA area, -0.42 [95% CI, -0.56 to-0.28] mL/min/1.73m2 for peak TR velocity, and -0.11 [95% CI, -0.20 to-0.01] mL/min/1.73m2 for EF, respectively). LIMITATIONS: The possibility of residual confounding. CONCLUSIONS: Multiple aspects of cardiac structure and function were statistically significantly associated with the risk of KFRT. These findings suggest that cardiac abnormalities and incidence of KFRT are potentially on the same causal pathway related to the interaction between hypertension, heart failure, and coronary artery diseases. PLAIN-LANGUAGE SUMMARY: Heart disease and kidney disease are known to interact with each other. In this study, we examined whether cardiac abnormalities, as assessed by echocardiography, were linked to the subsequent progression of kidney disease among people living with chronic kidney disease (CKD). We found that people with abnormalities in heart structure and function had a greater risk of progression to advanced CKD that required kidney replacement therapy and had a faster rate of decline in kidney function. Our study indicates the potential role of abnormal heart structure and function in the progression of kidney disease among people living with CKD.
引用
- Ishigami J, Kansal M, Mehta R, et al. Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2023. PMID: 36935072. doi:10.1053/j.ajkd.2023.01.442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。